BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 26704029)

  • 1. Torsemide Versus Furosemide in Patients With Acute Heart Failure (from the ASCEND-HF Trial).
    Mentz RJ; Hasselblad V; DeVore AD; Metra M; Voors AA; Armstrong PW; Ezekowitz JA; Tang WH; Schulte PJ; Anstrom KJ; Hernandez AF; Velazquez EJ; O'Connor CM
    Am J Cardiol; 2016 Feb; 117(3):404-11. PubMed ID: 26704029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effectiveness of torsemide versus furosemide in heart failure patients: insights from the PROTECT trial.
    Mentz RJ; Velazquez EJ; Metra M; McKendry C; Chiswell K; Fiuzat M; Givertz MM; Voors AA; Teerlink JR; O'Connor CM
    Future Cardiol; 2015 Sep; 11(5):585-95. PubMed ID: 26403536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Torsemide versus furosemide after acute decompensated heart failure: a retrospective observational study.
    Rahhal A; Saad MO; Tawengi K; Assi AAR; Habra M; Ahmed D
    BMC Cardiovasc Disord; 2019 May; 19(1):127. PubMed ID: 31138146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can Torsemide and Combination of Loop Diuretics Improve Mortality in Patients with Chronic Heart Failure After Discharge?
    Yao Y; Zhang J; Zhang Y; Zhang R
    Int Heart J; 2018 Jul; 59(4):813-820. PubMed ID: 29877310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Torsemide versus furosemide in heart failure patients: insights from Duke University Hospital.
    Mentz RJ; Buggey J; Fiuzat M; Ersbøll MK; Schulte PJ; DeVore AD; Eisenstein EL; Anstrom KJ; OʼConnor CM; Velazquez EJ
    J Cardiovasc Pharmacol; 2015 May; 65(5):438-43. PubMed ID: 25945862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure: The TRANSFORM-HF Randomized Clinical Trial.
    Mentz RJ; Anstrom KJ; Eisenstein EL; Sapp S; Greene SJ; Morgan S; Testani JM; Harrington AH; Sachdev V; Ketema F; Kim DY; Desvigne-Nickens P; Pitt B; Velazquez EJ;
    JAMA; 2023 Jan; 329(3):214-223. PubMed ID: 36648467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diuretic response in acute heart failure-an analysis from ASCEND-HF.
    ter Maaten JM; Dunning AM; Valente MA; Damman K; Ezekowitz JA; Califf RM; Starling RC; van der Meer P; O'Connor CM; Schulte PJ; Testani JM; Hernandez AF; Tang WH; Voors AA
    Am Heart J; 2015 Aug; 170(2):313-21. PubMed ID: 26299229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Torsemide Versus Furosemide on Symptoms and Quality of Life Among Patients Hospitalized for Heart Failure: The TRANSFORM-HF Randomized Clinical Trial.
    Greene SJ; Velazquez EJ; Anstrom KJ; Clare RM; DeWald TA; Psotka MA; Ambrosy AP; Stevens GR; Rommel JJ; Alexy T; Ketema F; Kim DY; Desvigne-Nickens P; Pitt B; Eisenstein EL; Mentz RJ;
    Circulation; 2023 Jul; 148(2):124-134. PubMed ID: 37212600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effectiveness of loop diuretics on mortality in the treatment of patients with chronic heart failure - A multicenter propensity score matched analysis.
    Täger T; Fröhlich H; Grundtvig M; Seiz M; Schellberg D; Goode K; Kazmi S; Hole T; Katus HA; Atar D; Cleland JGF; Agewall S; Clark AL; Frankenstein L
    Int J Cardiol; 2019 Aug; 289():83-90. PubMed ID: 30827731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Torsemide vs Furosemide Among Patients With New-Onset vs Worsening Chronic Heart Failure: A Substudy of the TRANSFORM-HF Randomized Clinical Trial.
    Krim SR; Anand S; Greene SJ; Chen A; Wojdyla D; Vilaro J; Haught H; Herre JM; Eisenstein EL; Anstrom KJ; Pitt B; Velazquez EJ; Mentz RJ
    JAMA Cardiol; 2024 Feb; 9(2):182-188. PubMed ID: 37955908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating a biomarker-driven approach to target collagen turnover in diabetic heart failure with preserved ejection fraction patients. Effect of torasemide versus furosemide on serum C-terminal propeptide of procollagen type I (DROP-PIP trial).
    Trippel TD; Van Linthout S; Westermann D; Lindhorst R; Sandek A; Ernst S; Bobenko A; Kasner M; Spillmann F; González A; López B; Ravassa S; Pieske B; Paulus WJ; Díez J; Edelmann F; Tschöpe C
    Eur J Heart Fail; 2018 Mar; 20(3):460-470. PubMed ID: 28891228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Effect of Loop Diuretic Prescription on Mortality and Heart Failure Readmission.
    Virkud AV; Chang PP; Funk MJ; Kshirsagar AV; Edwards JK; Pate V; Kosorok MR; Gower EW
    Am J Cardiol; 2024 Jan; 210():208-216. PubMed ID: 37972425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive review of the loop diuretics: should furosemide be first line?
    Wargo KA; Banta WM
    Ann Pharmacother; 2009 Nov; 43(11):1836-47. PubMed ID: 19843838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Worsening heart failure during hospitalization for acute heart failure: Insights from the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF).
    Kelly JP; Mentz RJ; Hasselblad V; Ezekowitz JA; Armstrong PW; Zannad F; Felker GM; Califf RM; O'Connor CM; Hernandez AF
    Am Heart J; 2015 Aug; 170(2):298-305. PubMed ID: 26299227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loop diuretic dose adjustments after a hospitalization for heart failure: insights from ASCEND-HF.
    DeVore AD; Hasselblad V; Mentz RJ; O'Connor CM; Armstrong PW; McMurray JJ; Ezekowitz JA; Tang WH; Starling RC; Voors AA; Califf RM; Hernandez AF
    Eur J Heart Fail; 2015 Mar; 17(3):340-6. PubMed ID: 25619549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-Analysis Comparing Torsemide Versus Furosemide in Patients With Heart Failure.
    Abraham B; Megaly M; Sous M; Fransawyalkomos M; Saad M; Fraser R; Topf J; Goldsmith S; Simegn M; Bart B; Azzo Z; Mesiha N; Sharma R
    Am J Cardiol; 2020 Jan; 125(1):92-99. PubMed ID: 31699358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Torsemide versus furosemide and intermediate-term outcomes in patients with heart failure: an updated meta-analysis.
    Miles JA; Hanumanthu BK; Patel K; Chen M; Siegel RM; Kokkinidis DG
    J Cardiovasc Med (Hagerstown); 2019 Jun; 20(6):379-388. PubMed ID: 30950982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous Diuretic Therapy for the Management of Heart Failure and Volume Overload in a Multidisciplinary Outpatient Unit.
    Buckley LF; Carter DM; Matta L; Cheng JW; Stevens C; Belenkiy RM; Burpee LJ; Young MA; Weiffenbach CS; Smallwood JA; Stevenson LW; Desai AS
    JACC Heart Fail; 2016 Jan; 4(1):1-8. PubMed ID: 26656139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Torsemide Versus Furosemide After Discharge in Patients Hospitalized With Heart Failure Across the Spectrum of Ejection Fraction: Findings From TRANSFORM-HF.
    Kapelios CJ; Greene SJ; Mentz RJ; Ikeaba U; Wojdyla D; Anstrom KJ; Eisenstein EL; Pitt B; Velazquez EJ; Fang JC;
    Circ Heart Fail; 2024 Mar; 17(3):e011246. PubMed ID: 38436075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Furosemide Versus Torsemide on Hospitalizations and Mortality in Patients With Heart Failure: A Meta-Analysis of Randomized Controlled Trials.
    Singh S; Goel S; Duhan S; Chaudhary R; Garg A; Tantry US; Gurbel PA
    Am J Cardiol; 2023 Nov; 206():42-48. PubMed ID: 37677884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.